欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
肝细胞癌（hepatocellular carcinoma，HCC）是发病率最高的恶性肿瘤之一，在我国也是癌症导致死亡的主要原因。HCC的早期诊断可显著提高患者生存率。长期以来，血清肿瘤标志物检测用于HCC诊断一直是最有效的方法之一，其中甲胎蛋白（AFP）含量的检测在世界范围内应用最广，但其诊断敏感性和特异性均存在缺陷。寻找HCC特异性标志物一直是相关研究的热点。本文概述了临床常用的多种HCC诊断相关分子。多种新分子的发现有望作为AFP的有效补充，从而提高HCC的诊断率。
英文摘要：
Hepatocellular carcinoma （HCC） ,one of the most common malignant tumors,ls the main cause of cancer death in China. Early diagnosis of the disease is of great importance. Serum tumor markers have been effective for detecting HCC for a long time. Among those markers, alpha fetoprotein （AFP） is the most widely used one in detecting patients with HCC, but it has limited utility for detecting HCC due to its limited sensitivity and specificity. Searching better markers for HCC has been a research focus in recent years. This review introduces many useful markers to supplement AFP for detecting HCC.
同期刊论文项目
同项目期刊论文
Transforming grwoth factor β1 gene variants increase transcription and are associated with liver cir
Nglycomic change in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B vi
Association of a variant in MIR 196A 2 with susceptibility to hepatocellular carcinoma in male Chine
An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibi
No association of EGF 5'UTR variant A 61G and hepatocellular carcinoma in Chinese patients with chro
位置：